Moderna to Present at Upcoming Conferences in March 2025
Moderna (Nasdaq: MRNA) has announced its upcoming participation in two major investor conferences in March 2025. The company will present at the TD Cowen 45th Annual Health Care Conference on Wednesday, March 5th at 9:10am ET, and at the Barclays 27th Annual Global Healthcare Conference on Tuesday, March 11th at 1:30pm ET.
Investors and interested parties can access live webcasts of both presentations through the "Events and Presentations" section of Moderna's investor website at investors.modernatx.com. For those unable to attend the live events, replays of the webcasts will remain available on the company's website for at least 30 days following each presentation.
Moderna (Nasdaq: MRNA) ha annunciato la sua prossima partecipazione a due importanti conferenze per investitori nel marzo 2025. L'azienda presenterà alla 45ª Conferenza Annuale sulla Salute di TD Cowen mercoledì 5 marzo alle 9:10 ET, e alla 27ª Conferenza Globale Annuale sulla Salute di Barclays martedì 11 marzo alle 13:30 ET.
Gli investitori e le parti interessate possono accedere a webcast in diretta di entrambe le presentazioni attraverso la sezione
Moderna (Nasdaq: MRNA) ha anunciado su próxima participación en dos importantes conferencias para inversores en marzo de 2025. La compañía presentará en la 45ª Conferencia Anual de Salud de TD Cowen el miércoles 5 de marzo a las 9:10 a.m. ET, y en la 27ª Conferencia Global Anual de Salud de Barclays el martes 11 de marzo a la 1:30 p.m. ET.
Los inversores y partes interesadas pueden acceder a transmisiones en vivo de ambas presentaciones a través de la sección
모더나 (Nasdaq: MRNA)는 2025년 3월에 두 개의 주요 투자자 회의에 참가할 예정이라고 발표했습니다. 이 회사는 3월 5일 수요일 오전 9시 10분 ET에 TD Cowen 제45회 연례 의료 회의에서 발표하며, 3월 11일 화요일 오후 1시 30분 ET에 바클레이즈 제27회 연례 글로벌 의료 회의에서 발표할 예정입니다.
투자자 및 관심 있는 당사자는 모더나의 투자자 웹사이트의
Moderna (Nasdaq: MRNA) a annoncé sa prochaine participation à deux grandes conférences pour investisseurs en mars 2025. La société présentera à la 45e Conférence Annuelle sur la Santé de TD Cowen le mercredi 5 mars à 9h10 ET, et à la 27e Conférence Annuelle Mondiale sur la Santé de Barclays le mardi 11 mars à 13h30 ET.
Les investisseurs et les parties intéressées peuvent accéder aux webcasts en direct des deux présentations via la section
Moderna (Nasdaq: MRNA) hat seine bevorstehende Teilnahme an zwei wichtigen Investorenkonferenzen im März 2025 angekündigt. Das Unternehmen wird am Mittwoch, den 5. März um 9:10 Uhr ET auf der 45. Jahreskonferenz für Gesundheitswesen von TD Cowen präsentieren und am Dienstag, den 11. März um 13:30 Uhr ET auf der 27. Jahreskonferenz für globales Gesundheitswesen von Barclays.
Investoren und Interessierte können die Live-Webcasts beider Präsentationen über den Bereich
- None.
- None.
CAMBRIDGE, MA / ACCESS Newswire / February 25, 2025 / Moderna, Inc. (Nasdaq: MRNA), today announced its participation in the following upcoming investor conferences:
TD Cowen 45th Annual Health Care Conference, on Wednesday, March 5th at 9:10am ET
Barclays 27th Annual Global Healthcare Conference, on Tuesday, March 11th at 1:30pm ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.
Webcast: investors.modernatx.com.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Moderna presenting at the TD Cowen Health Care Conference in March 2025?
What investor conferences will MRNA participate in during March 2025?
How can investors access Moderna's March 2025 conference presentations?
How long will replays of MRNA's March 2025 conference presentations be available?
What time is Moderna's presentation at the Barclays Global Healthcare Conference in March 2025?
